Comerica Bank’s MacroGenics MGNX Stock Holding History

Comerica Bank’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$71	Hold	44	–	–	﹤0.01%	3692
2025 Q3	$74	Hold	44	–	–	﹤0.01%	3693
2025 Q2	$53	Hold	44	–	–	﹤0.01%	3677
2025 Q1	$56	Hold	44	–	–	﹤0.01%	3667
2024 Q4	$143	Buy	+44	New	+$158	﹤0.01%	3645
2024 Q3	–	Sell	-44	Closed	-$187	–	3735
2024 Q2	$187	Hold	44	–	–	﹤0.01%	3664
2024 Q1	$648	Buy	+44	New	+$665	﹤0.01%	3657

Other funds holding MGNX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Comerica Bank's MGNX Position: Q4 2025 in Review

Comerica Bank held its MacroGenics (MGNX) position steady in Q4 2025 at 44 shares worth $71. The position accounts for ﹤0.01% of the portfolio, ranked #3692.

Comerica Bank first reported a position in MGNX in Q1 2024 and has held it in 7 quarters since. The position peaked at $648 in Q1 2024. 88 funds tracked by Wall St. Rank hold MGNX as of Q4 2025.

Comerica Bank held 44 shares of MacroGenics worth $71 as of Q4 2025.
Comerica Bank left its MacroGenics share count unchanged in Q4 2025.
MacroGenics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3692 holding.
Comerica Bank first reported a position in MacroGenics in Q1 2024 and has held it in 7 quarters since.
Comerica Bank's MacroGenics position peaked at $648 in Q1 2024.
88 funds tracked by Wall St. Rank held MacroGenics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.